PMID: 20123546DOI: 10.1016/s1353-8020(09)70845-4Feb 4, 2010Paper
Dopamine receptor agonists and sleep disturbances in Parkinson's disease
Parkinsonism & Related Disorders
K Ray Chaudhuri, Kartik Logishetty
Abstract
Non-ergot dopamine receptor agonists, such as ropinirole, pramipexole, rotigotine and apomorphine, may alleviate some non-motor symptoms in Parkinson's disease (PD) while others may be precipitated. In this review, we discuss how dopamine receptor agonists can both ameliorate and aggravate the sleep problems in PD, a key non-motor symptom of this disease.
References
Sep 1, 1979·Neurology·R P LesserR E Barrett
Jan 1, 1993·Neurourology and Urodynamics·B Aranda, P Cramer
May 1, 1996·The European Respiratory Journal·P PfitzenmeyerP Camus
Aug 6, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·R A HauserT A Zesiewicz
Mar 15, 2001·Parkinsonism & Related Disorders·W J. WeinerC Doyle
Feb 13, 2002·Neurology·E K TanM C Wong
Mar 14, 2002·Archives of Neurology·William G OndoJoseph Jankovic
Aug 28, 2002·Neurology·J F GagnonJ Montplaisir
Sep 25, 2003·Neurology·G Van CampD Schoors
Nov 1, 2003·Sleep Medicine·John W Winkelman
Nov 1, 2003·Sleep Medicine·Joan SantamariaEduard Tolosa
Jan 21, 2004·Archives of Neurology·Ajmal RazmyColin M Shapiro
Nov 2, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Melissa J Nirenberg, Cheryl Waters
Apr 4, 2007·Neurology·R PahwaUNKNOWN EASE-PD Adjunct Study Investigators
Nov 18, 2008·Neurocase·Hideto Miwa, Tomoyoshi Kondo
Jan 29, 2009·CNS Drugs·Sean S O'SullivanAndrew J Lees
❮ Previous
Next ❯
Citations
Jul 4, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S StefansdottirJ P Larsen
Jun 21, 2011·Parkinson's Disease·Heinz ReichmannPablo Martinez-Martin
Jul 6, 2014·Journal of Neural Transmission·Fabrizio Stocchi, Paola Stirpe
Aug 31, 2011·Parkinson's Disease·Keisuke SuzukiKoichi Hirata
Jul 28, 2016·Sleep Medicine·Mariangela PierantozziAlessandro Stefani
Feb 5, 2016·CNS Neuroscience & Therapeutics·Bai-Yun Zeng, Kaicun Zhao
Sep 4, 2010·Revue neurologique·V Cochen De Cock, Y Dauvilliers
Nov 2, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Tasneem PeeraullyEng-King Tan
Feb 22, 2012·Journal of the Neurological Sciences·Sanjay Prakash
Feb 18, 2015·Current Neurology and Neuroscience Reports·Keisuke SuzukiKoichi Hirata
Mar 21, 2015·Parkinson's Disease·Javier PagonabarragaJaime J Kulisevsky
Oct 22, 2016·Journal of Parkinson's Disease·Gustavo Fernández-PajarínAlfonso Castro
Aug 19, 2011·European Neurology·Manoel Alves Sobreira NetoAlan Luiz Eckeli
Dec 13, 2016·Parkinsonism & Related Disorders·Roongroj BhidayasiriK Ray Chaudhuri
Apr 4, 2020·Journal of Geriatric Psychiatry and Neurology·Amitha DhingraAdriana P Hermida
May 2, 2019·Frontiers in Neurology·Chun-Wei ChangYih-Ru Wu
Subthalamic Stimulation Improves Quality of Sleep in Parkinson Disease: A 36-Month Controlled Study.
Oct 20, 2020·Journal of Parkinson's Disease·Stefanie T JostUNKNOWN EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group
Mar 4, 2017·Journal of Acupuncture and Meridian Studies·Fábio Henrique de Amorim AroxaNadja Maria Jorge Asano
❮ Previous
Next ❯
Related Concepts
Related Feeds
Bladder Carcinoma In Situ
Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.
Related Papers
Movement Disorders : Official Journal of the Movement Disorder Society
O SuchowerskyG Rohs
British Journal of Clinical Pharmacology
Joëlle MicallefOliver Blin
Parkinsonism & Related Disorders
Isabelle Arnulf, Smaranda Leu-Semenescu
Clinical Neuropharmacology
A J LeesV L Campbell